Compare Lustrum:Delta-Fly Pharma,Inc.:4598

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Delta-Fly Pharma,Inc. 4598 Medicals 東証グロース March 1, 2000 2018.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Delta-Fly Pharma,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Balance Sheet 2023年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2022年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2021年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2020年3月期 Delta-Fly Pharma,Inc. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
844down
(93.1%)down
1,268down
(95.8%)down
2,089up
(96.6%)up
1,944down
(89.9%)down
3,508
(98.3%)
Other Current AssetsHelp
(Percent)
22up
(2.4%)up
12down
(0.9%)down
27down
(1.2%)down
172up
(7.9%)up
24
(0.7%)
Tangible Fixed AssetsHelp
(Percent)
39down
(4.3%)up
40down
(3.0%)up
42down
(1.9%)down
43up
(2.0%)up
32
(0.9%)
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0down
(0.0%)down
0down
(0.0%)down
0
(0.0%)
Investments and OthersHelp
(Percent)
2down
(0.2%)down
4down
(0.3%)up
4up
(0.2%)up
3down
(0.2%)up
4
(0.1%)
Total AssetsHelp
(Percent)
907
(100%)
1,324
(100%)
2,161
(100%)
2,162
(100%)
3,567
(100%)
Total Current LiabilitiesHelp
(Percent)
116up
(12.7%)up
91up
(6.9%)up
82down
(3.8%)down
106up
(4.9%)up
50
(1.4%)
Total Long-term LiabilitiesHelp
(Percent)
0
-
0
-
0
-
0
-
13
(0.4%)
Shareholder's EquityHelp
(Percent)
791down
(87.3%)down
1,233down
(93.1%)down
2,079up
(96.2%)up
2,056down
(95.1%)down
3,504
(98.2%)
Total LiabilitiesHelp
(Percent)
907
(100%)
1,324
(100%)
2,161
(100%)
2,162
(100%)
3,567
(100%)

Delta-Fly Pharma,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Profit and Loss Account 2023年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2022年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2021年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2020年3月期 Delta-Fly Pharma,Inc. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
0
(100%)
300
(100%)
300
(100%)
100
(100%)
0
(100%)
Total Sales
(Percent)
0
(100%)
300
(100%)
300
(100%)
100
(100%)
0
(100%)
Cost of SalesHelp
(Percent)

-

-

-

-
593
Other Costs and RevenueHelp 1,329up
1,267up
(422.4%)up
1,163down
(387.5%)down
1,656up
(1,655.8%)
81
Total CostsHelp 1,329 1,267 1,163 1,656 674
Net RevenueHelp
-

-

-

-
-593
Earnings Before TaxHelp -1,326down
-964down
(-321.4%)down
-859up
(-286.5%)up
-1,552down
(-1,552.2%)
-671
Net IncomeHelp -1,329down
-967down
(-322.4%)down
-863up
(-287.5%)up
-1,556down
(-1,555.8%)
-674
当期純利益 -1,329 -967 -863 -1,556 -674

Delta-Fly Pharma,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Delta-Fly Pharma,Inc. Cash Flow Statement 2023年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2022年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2021年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2020年3月期 Delta-Fly Pharma,Inc. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
-1,303down
(-99.9%)up
-940down
(-100.0%)down
-727up
(-83.0%)up
-1,649down
(-99.1%)down
-585
(-17.6%)
Investing Cash Flow(ICF)Help
(Percent)

-
-0up
(0.0%)up
-1
(-0.1%)down
-1up
(0.0%)up
-13
(-0.4%)
Financing Cash FlowHelp
(Percent)
883up
(67.6%)up
120down
(12.7%)down
875up
(100.0%)up
100down
(6.0%)down
3,317
(99.7%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)

-
1up
(0.1%)up
-3up
(-0.4%)up
-15down
(-0.9%)down
9
(0.3%)
Net Increase and Decrease in Cash and Cash Equivalentsn -424up
(-32.5%)up
-820down
(-87.2%)down
145up
(16.5%)up
-1,565down
(-94.0%)down
2,727
(82.0%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Delta-Fly Pharma,Inc.

Company where related level is highHelp

KAKEN PHARMACEUTICAL CO.,LTD.
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
Kyowa Kirin Co.,Ltd.
Daito Pharmaceutical Co.,Ltd.
CanBas Co.,Ltd.
DENKA SEIKEN Co.,Ltd.
SymBio Pharmaceuticals Limited
Modalis Therapeutics Corporation
Shionogi & Co.,Ltd.
Renascience Inc.